A Multimedia Approach to Informed Consent Mildred Z. Solomon, EdD Vice President, Education Development Center, Inc (EDC) Director, EDC’s Center for Applied.

Slides:



Advertisements
Similar presentations
THE COMMONWEALTH FUND Developing Innovative Payment Approaches: Finding the Path to High Performance Stuart Guterman Vice President, Payment and System.
Advertisements

Your Clinical Research Knowledge  B Smith, ORI, 2012.
Conflict of Interest (COI) Objectives: Provide an overview of financial conflict of interest (FCOI) related to research activities at Gillette Describe.
Turning Questions into Trials: Innovation in Surgical Oncology Jennifer E. Rosen MD FACS Assistant Professor of Surgery and Molecular Medicine Boston University.
HIV Clinical Trials Janice Price, M.Ed, RN HIV Clinical Research Program Coordinator Swedish Medical Center Seattle, WA USA.
Are you Using Technology to Assess Learning or Assessing Learning to Improve Technology? Marilee J. Bresciani, Ph.D. Associate Professor, Postsecondary.
Columbia University IRB IRB 101 September 21, 2005 George Gasparis, Executive Director, CU IRB Asst. V.P. and Sr. Asst. Dean for Research Ethics.
Identification & Distinction of Clinical Trial Participant Charges Bethany Martell Office of Clinical Research Associate Director- Financial Operations.
CUMC IRB Investigator Meeting November 9, 2004 Research Use of Stored Data and Tissues.
UNDERSTANDING DATA AND INFORMATION FLOW Session 4.
Institutional Review Boards (IRB) for Indian Health Research.
Informed Consent and HIPAA Tim Noe Coordinating Center.
ETHICAL RESEARCH © 2012 The McGraw-Hill Companies, Inc.
Research Methods for the Social Sciences: Ethics Ryan J. Martin, Ph.D. Thomas N. Cummings Research Fellow March 9, 2010.
Ethical Issues in Research
Why companies saying or should say “YES” to India for Studies.
METHODS IN BEHAVIORAL RESEARCH NINTH EDITION PAUL C. COZBY Copyright © 2007 The McGraw-Hill Companies, Inc.
Ethical Issues and Treatment Policies. [This document is part of the « Malaria Indicator Survey » toolkit, developed by the RBM-MERG, with contributions.
Clinical Trials. What is a clinical trial? Clinical trials are research studies involving people Used to find better ways to prevent, detect, and treat.
Workshop on Health Examination Surveys (HES) Legal and ethical issues Susanna Conti, M. Kanieff, G. Rago Istituto Superiore di Sanità (ISS) (National Public.
IRB and the Community Member How You Can Get Involved Mary Lou Smith Elda Railey Conference Call Series on IRBs and Ethical Issues in Research Co-sponsored.
Darren A. DeWalt, MD, MPH Division of General Internal Medicine Maihan B. Vu, Dr.PH, MPH Center for Health Promotion and Disease Prevention University.
Testing People Scientifically.  Clinical trials are research studies in which people help doctors and researchers find ways to improve health care. Each.
Institutional Review Board (IRB) Human Subject Dr. John N. Austin, Director and Ms. Renee S. Jones, Associate Director Delaware State University Office.
Institutional Review Board (IRB) for Human Subject Protections: Working with the IRB Erin McClure, PhD Department of Psychiatry and Behavioral Sciences.
Risk by Richard R. Riker MD Vice-Chair, IRB Maine Medical Center.
The Global Health Network Marijke Geldenhuys 19 September 2014 Adhering to the GCP Principles.. what does that even mean?
Legal & Ethical Issues. Objectives At the completion of this session the participant will be able to: ◦ Describe the ethical principles associated with.
University of North Carolina at Greensboro Protecting Research Participants.
Special Consideration in Public Health Practice & Research Delia Wolf, MD, JD, MSCI Associate Dean, Regulatory Affairs and Regulatory Compliance Lecturer,
Belinda Seto, Ph.D. Acting Deputy Director for Extramural Research National Institutes of Health Human Subjects Research Enhancements Awards Renaissance.
Consent for Research Study A study using 18 F-Fluoride for prostate cancer patients currently enrolled in Dr. Febbo’s “Genomic Guided Therapy” study A.
PA Profession ETHICS COMMITTEE RIGHT TO REFUSE TREATMENT Salvatore Barese, PA-C.
Clinical Trials and Research A Guide for Community Advisory Board Members Participant Manual.
Quality and Safety Education for Nurses The QSEN Project.
Yadvindera (Bobby) Bains MD Director of Radiation Oncology, Laredo Medical Center Adjunct Associate Professor, Dept of Radiation Oncology, University of.
Human Genetics and Genetic Technology Using Genetic InformationUsing Genetic Information.
AAHRPP ACCREDITATION (Association for the Accreditation of Human Protection Programs)
$100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 $100 $200 $400 $500 $300 Terms Clinical Trial Facts.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
Objective 9/23/15 Today we will be completing our research methods unit & begin reviewing for the upcoming unit assessment 9/25. Agenda: -Turn in all homework.
Cultural Competence Considerations [and other alliterations] in International Research IRB 2 Continuing Education March 10, 2015.
5-6-1 Unit 6: Ethical considerations After completing this unit, you should be able to: Understand the basic ethical principles of working with.
Understanding Clinical Trials – Part 2 Georgianne Arnold, MD Professor of Pediatrics University of Pittsburgh Medical Center Pittsburgh Children’s Hospital.
Paul Kelly Facility Research Compliance Officer for the Ralph H. Johnson VA Medical Center.
Chapter 6 Designing Experiments. Is it ethical? A promising new drug has been developed for treating cancer in humans. Researchers want to administer.
NCI/NAPBC Model Informed Consent for Future Research Use of Tissue Marianna Bledsoe Resources Development Branch, Cancer Diagnosis Program, National Cancer.
Second Annual Medical Research Summit March 25, 2002 Washington, D.C.
Ethical issues with the regulatory use of gene expression data Benjamin S Wilfond MD Medical Genetics Branch National Human Genome Research Institute Department.
SoTL Research and the IRB Process Kathleen McKinney, Cross Chair in SoTL Nancy Latham, Campus IRB Executive Committee Phyllis McCluskey-Titus, SoTL Scholar.
Copyright c 2001 The McGraw-Hill Companies, Inc.1 Chapter 5 Research Ethics All researchers, even students, have a responsibility to conduct ethical research.
Doing IRB Right … Together JOHN POTTER, OD, MA Chair, Institutional Review Board.
Institutional Review Board (IRB) for Human Subject Protections: Working with the IRB Erin A McClure, PhD Department of Psychiatry and Behavioral Sciences.
 The purpose of IRB is to ensure the rights of research subjects are protected  In accordance with the ethical standards of the U.S. Department of Health.
Suggested Guidelines: Community Member Compensation for Serving on CTSA Domain Task Forces Prepared by: Compensation Workgroup of the Collaboration / Engagement.
Quality Metrics of Performance of Research Ethics Committees Cristina E. Torres, PhD FERCAP Coordinator.
JENNIFER WATSON, MA NATIONAL INSTITUTE ON AGING, NIH MAY 19, 2016 Healthy Aging & Participation in Research What Older Adults Should Know.
CLINICAL TRIALS.
Raising Awareness. Funding Research.
Chapter 3: Ethical guidelines for psychological research.
Session: 5 Using the RDQA tool for System Assessment
Clinical Trials Medical Interventions
Bozeman Health Clinical Research
© 2016 The McGraw-Hill Companies, Inc.
Genetic Information Nondiscrimination Act (GINA)
Cindy Murray NP Princess Margaret Cancer Centre
The Center for Nursing Research Ochsner Health System December 2015
Research, Experimentation, & Clinical Trials
Genomic Medicine in Community Health: Protecting Human Rights
Interviewer Research Ethics
Presentation transcript:

A Multimedia Approach to Informed Consent Mildred Z. Solomon, EdD Vice President, Education Development Center, Inc (EDC) Director, EDC’s Center for Applied Ethics Associate Clinical Professor of Medical Ethics, Harvard Medical School Presented to Secretary’s Advisory Committee on Human Research Protection October 28, 2009 Washington, DC

An electronic approach can improve…  Understanding  Inclusiveness  Transparency  Standardization

Can improve understanding by…  Visuals which illustrate  Easy-to-understand colloquial speech  Monitoring respondents’ answers to key questions

Can improve inclusiveness by… Picturing people from diverse:  Ethnic groups  Socio-economic classes  Regions of the country

Can improve transparency by…  Making it clear how the study was explained during the informed consent encounter

Can improve standardization by…  Ensuring that everyone has the same things explained to them, and in the same manner

1.Inform the subject Provide information purpose and scope of the study, what participation involves, and the risks and benefits of participating 2.Assess understanding Evaluate a potential subject’s comprehension 3.Obtain consent Give those who have demonstrated understanding of the information an opportunity to sign their consent Three functions an e-consent tool can perform

Structure of E-Consent Tool Follows federal requirements:  Explains study purposes  Describes what is involved in participation  Explains benefits and risks  Describes compensation if any  Addresses commonly asked questions  Asks for a decision If yes, captures e-signature If no, provides thank you and may ask why

The North Carolina Registry Informed Consent Project Participating Institutions: North Carolina Cancer Hospital UNC Lineberger Comprehensive Cancer Center UNC Gillings School of Global Public Health UNC School of Medicine Funded by: University Cancer Research Fund

The North Carolina Registry Informed Consent Project At University of North Carolina, Chapel Hill: H. Shelton Earp III, MD Debra E. Irwin, PhD, MSPH Jeannette Bensen, PhD, MS At Education Development Center, Inc.: Mildred Z. Solomon, EdD Sarah McGraw, PhD Carol Nutter, BS

Format Preferences of Video and Read-only Groups

How Likely Are You to Join the Study?

A Federal law called the Genetic Information Nondiscrimination Act (GINA)… makes it illegal for health insurance companies, group health plans, and most employers to discriminate against you based on your genetic information. More information about GINA is found in the written consent form.

Who will decide what research will be done using the Registry? Each time researchers want to use the Registry, they will have to describe their research study to an Institutional Review Board or IRB. The IRB is responsible for protecting human research participants. Both a Registry governing committee and the IRB will have to approve the study.

Who will decide what research will be done using the Registry? (cont.) At times, the governing committee or the IRB may ask a researcher to re-contact you to consider participation in a particular, future research study. This would happen if the committee or the IRB thought that the proposed research was something Registry volunteers would want to think more about, before allowing their samples to be analyzed. If you are re-contacted, you could say yes or no to having your stored samples and data used in such a research study.

How many people will take part in this research and how long will the study last? If you decide to participate, you will be one of many thousands of people identified over the course of many years. Approximately 10,000 people will be followed annually.